Log In
BCIQ
Print this Print this
 

INM-750

  Manage Alerts
Collapse Summary General Information
Company InMed Pharmaceuticals Inc.
DescriptionCompound comprising cannabinoids and undisclosed non-cannabis based active ingredients
Molecular Target Cannabinoid receptors
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBlistering disorder
Indication DetailsTreat epidermolysis bullosa simplex
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today